Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds DA Davidson Maintains Neutral on Volta, Lowers Price Target to $1

DA Davidson Maintains Neutral on Volta, Lowers Price Target to $1

DA Davidson analyst Matt Summerville maintains Volta (NYSE:VLTA) with a Neutral and lowers the price target from $2 to $1.

byBenzinga Newsdesk

November 16, 2022

1 minute read

DA Davidson analyst Matt Summerville maintains Volta (NYSE:VLTA) with a Neutral and lowers the price target from $2 to $1.

Analyst Ratings

The Latest Analyst Ratings for Scotts Miracle Gro

By Benzinga Insights

April 6, 5:01 PM

Within the last quarter, Scotts Miracle Gro (NYSE:SMG) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent…

SMG

Global
News

China Files Dispute At World Trade Organization Against Us Chip Export Curbs

By Benzinga Newsdesk

December 12, 11:33 AM

- Reuters

AMD

AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression

By Vandana Singh

April 24, 11:24 AM

Ionis Pharmaceuticals Inc (NASDAQ:IONS) and AstraZeneca Plc (NASDAQ:AZN) announced that the Phase 3 NEURO-TTRansform study for eplontersen in patients with hereditary…

AZN

Blue Bird Corporation Posts Top, Bottomline Beats For Q2, Raises FY24 Guidance

By Ryan Gustafson

December 11, 6:40 PM

Blue Bird Corp (NASDAQ: BLBD) shares are trading higher in Monday's after-hours session after the company reported better-than-expected fourth-quarter financial results and increased full-year 2024 revenue guidance.

BLBD

DA Davidson Maintains Neutral on Volta, Lowers Price Target to $1

Related Posts

The Latest Analyst Ratings for Scotts Miracle Gro

China Files Dispute At World Trade Organization Against Us Chip Export Curbs

AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression

Blue Bird Corporation Posts Top, Bottomline Beats For Q2, Raises FY24 Guidance